stoxline Quote Chart Rank Option Currency Glossary
  
LHA Market State Tactical Q ETF (MSTQ)
39.26  0.292 (0.75%)    11-26 15:55
Open: 39
High: 39.26
Volume: 10,492
  
Pre. Close: 38.9683
Low: 39
Market Cap: 30(M)
Technical analysis
2025-11-26 4:50:41 PM
Short term     
Mid term     
Targets 6-month :  46.81 1-year :  48.32
Resists First :  40.07 Second :  41.36
Pivot price 39.18
Supports First :  37.98 Second :  31.6
MAs MA(5) :  38.49 MA(20) :  39.55
MA(100) :  38.24 MA(250) :  35.2
MACD MACD :  -0.3 Signal :  -0.2
%K %D K(14,3) :  32.1 D(3) :  19
RSI RSI(14): 49.6
52-week High :  41.36 Low :  29.14
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ MSTQ ] has closed below upper band by 47.4%. Bollinger Bands are 64.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 9 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 39.29 - 39.47 39.47 - 39.65
Low: 38.51 - 38.73 38.73 - 38.94
Close: 38.91 - 39.24 39.24 - 39.56
Company Description

The fund is an actively-managed exchange-traded fund (“ETF”) that seeks to achieve its objective principally by investing in equity instruments linked directly or indirectly to the performance of U.S.-listed, large capitalization, growth-oriented companies (“growth equities”) based on models and analyses that seek to estimate the direction of growth equities. The fund is non-diversified.

Headline News

Sat, 22 Nov 2025
(MSTQ) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Tue, 11 Nov 2025
(MSTQ) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Wed, 08 Oct 2025
The One Asset Class You Should Include In Your Portfolio - Seeking Alpha

Thu, 17 Oct 2024
An ETF Strategy for Tailored Market Hedging - ETF.com

Fri, 18 Mar 2022
ETF Odds & Ends: Avantis Debuts ESG ETFs - ETF.com

Thu, 27 Nov 2025

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
CBOE
Sector:
Financial Services
Industry:
Asset Management
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android